Zofia Malas
Overview
Explore the profile of Zofia Malas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smieszek A, Marcinkowska K, Malas Z, Sikora M, Kepska M, Nowakowska B, et al.
BMC Cancer
. 2024 Feb;
24(1):105.
PMID: 38342891
Background: Histiocytoses are rare disorders manifested by increased proliferation of pathogenic myeloid cells sharing histological features with macrophages or dendritic cells and accumulating in various organs, i.a., bone and skin....
2.
Sobieraj P, Malas Z, Issat T, Raciborska A, Bekiesinska-Figatowska M
Ginekol Pol
. 2023 Aug;
PMID: 37642250
Objectives: Rhabdomyosarcoma of the genitourinary system in girls is a rare neoplasm, especially in non-dedicated centers. Our work aimed to sum up and present genitourinary rhabdomyosarcomas in girls from the...
3.
Richert-Przygonska M, Czyzewski K, Dziedzic M, Zalas-Wiecek P, Gryniewicz-Kwiatkowska O, Gietka A, et al.
Pediatr Infect Dis J
. 2022 Jul;
41(10):846-850.
PMID: 35797710
Background: Infections caused by Stenotrophomonas maltophilia (SM) have documented high mortality rate in immunocompromised patients. Aim: This nationwide multicenter study was performed to analyze the epidemiology of SM infections in...
4.
Zajac-Spychala O, Wachowiak J, Gryniewicz-Kwiatkowska O, Gietka A, Dembowska-Baginska B, Semczuk K, et al.
Microb Drug Resist
. 2020 May;
27(1):53-63.
PMID: 32434455
Infectious complications (IC) caused by bacterial strains often impede anticancer therapy. The study aimed to retrospectively analyze bacterial IC that could help predict the risk and optimize the empirical treatment...
5.
Czyzewski K, Galazka P, Fraczkiewicz J, Salamonowicz M, Szmydki-Baran A, Zajac-Spychala O, et al.
Mycoses
. 2019 Aug;
62(11):990-998.
PMID: 31429997
The objective of the study was the analysis of incidence and outcome of invasive fungal disease (IFD) in children treated for malignancy (PHO, paediatric hematology-oncology) or undergoing hematopoietic cell transplantation...
6.
Czyzewski K, Galazka P, Zalas-Wiecek P, Gryniewicz-Kwiatkowska O, Gietka A, Semczuk K, et al.
Infect Drug Resist
. 2019 Jun;
12:1471-1480.
PMID: 31213862
The analysis of epidemiology, risk factors and outcome of infections in children with malignant bone tumors (MBT) undergoing chemotherapy. In this retrospective nationwide multicenter cross-sectional study, a total number of...
7.
Zajac-Spychala O, Skalska-Sadowska J, Wachowiak J, Szmydki-Baran A, Hutnik L, Matysiak M, et al.
Leuk Lymphoma
. 2019 May;
60(12):3028-3035.
PMID: 31132917
The aim of this nationwide study was to describe the epidemiology and profile of bacterial infections (BI), invasive fungal disease (IFD) and viral infections (VI) in patients with and relapsed/refractory...
8.
Zawitkowska J, Drabko K, Szmydki-Baran A, Zaucha-Prazmo A, Lejman M, Czyzewski K, et al.
J Infect Chemother
. 2019 May;
25(10):774-779.
PMID: 31101529
Introduction: The treatment-related mortality in currently published studies of acute lymphoblastic leukemia (ALL) in children is 2-4%, mainly due to infections. The aim of the study was to analyse the...
9.
Raciborska A, Malas Z, Tysarowski A
Dev Period Med
. 2019 Jan;
22(4):376-378.
PMID: 30636236
Langerhans Cell Histiocytosis (LCH) is a rare disease involving the occurrence of disturbances in the mitogene-activated kinases pathway (MAPK). At present, it is known that the appearance of such disorders...
10.
Zajac-Spychala O, Wachowiak J, Szmydki-Baran A, Hutnik L, Salamonowicz M, Matysiak M, et al.
Leuk Lymphoma
. 2018 Nov;
60(1):124-132.
PMID: 30392426
The objective of this nation-wide study was to evaluate the epidemiology and profile of bacterial (BI), viral (VI), and invasive fungal disease (IFD) in patients treated for non-Hodgkin lymphoma (NHL)...